These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
246 related articles for article (PubMed ID: 32894109)
1. Preoperative prostate health index predicts adverse pathology and Gleason score upgrading after radical prostatectomy for prostate cancer. Novak V; Vesely S; Luksanová H; Prusa R; Capoun O; Fiala V; Dolejsová O; Sedlacková H; Kucera R; Stejskal J; Zalesky M; Babjuk M BMC Urol; 2020 Sep; 20(1):144. PubMed ID: 32894109 [TBL] [Abstract][Full Text] [Related]
2. Preoperative Prostate-specific Antigen Isoform p2PSA and Its Derivatives, %p2PSA and Prostate Health Index, Predict Pathologic Outcomes in Patients Undergoing Radical Prostatectomy for Prostate Cancer: Results from a Multicentric European Prospective Study. Fossati N; Buffi NM; Haese A; Stephan C; Larcher A; McNicholas T; de la Taille A; Freschi M; Lughezzani G; Abrate A; Bini V; Palou Redorta J; Graefen M; Guazzoni G; Lazzeri M Eur Urol; 2015 Jul; 68(1):132-8. PubMed ID: 25139197 [TBL] [Abstract][Full Text] [Related]
3. Preoperative prostate-specific antigen isoform p2PSA and its derivatives, %p2PSA and prostate health index, predict pathologic outcomes in patients undergoing radical prostatectomy for prostate cancer. Guazzoni G; Lazzeri M; Nava L; Lughezzani G; Larcher A; Scattoni V; Gadda GM; Bini V; Cestari A; Buffi NM; Freschi M; Rigatti P; Montorsi F Eur Urol; 2012 Mar; 61(3):455-66. PubMed ID: 22078333 [TBL] [Abstract][Full Text] [Related]
4. Serum (-2)proPSA/freePSAratio, (-2)proPSA/freePSA density, prostate health index, and prostate health index density as clues to reveal postoperative clinically significant prostate cancer in men with prostate-specific antigen 2-10 ng/mL. Ferro M; Crocetto F; La Civita E; Fiorenza M; Jannuzzi G; Carbone G; Sirica R; Sicignano E; Pagano G; Imbimbo C; Terracciano D Prostate; 2024 Sep; 84(12):1157-1164. PubMed ID: 38798011 [TBL] [Abstract][Full Text] [Related]
5. Prostate health index density predicts aggressive pathological outcomes after radical prostatectomy in Taiwanese patients. Huang YP; Lin TP; Cheng WM; Wei TC; Huang IS; Fan YH; Lin CC; Huang EYH; Chung HJ; Kuo JY; Wu HHH; Lu SH; Chang YH; Lin ATL; Huang WJS J Chin Med Assoc; 2019 Nov; 82(11):835-839. PubMed ID: 31425303 [TBL] [Abstract][Full Text] [Related]
6. Prostate Health Index and %p2PSA Predict Aggressive Prostate Cancer Pathology in Chinese Patients Undergoing Radical Prostatectomy. Chiu PK; Lai FM; Teoh JY; Lee WM; Yee CH; Chan ES; Hou SM; Ng CF Ann Surg Oncol; 2016 Aug; 23(8):2707-14. PubMed ID: 26965697 [TBL] [Abstract][Full Text] [Related]
7. Preoperative prostate health index and %p2PSA as the significant biomarkers of postoperative pathological outcomes of prostate cancer in Korean males: A prospective multi-institutional study. Park H; Lee SW; Song G; Kang TW; Jung JH; Chung HC; Kim SJ; Park JY; Shin TY; Kim JH Investig Clin Urol; 2020 Jan; 61(1):42-50. PubMed ID: 31942462 [TBL] [Abstract][Full Text] [Related]
9. Use of the Prostate Health Index for the Detection of Aggressive Prostate Cancer at Radical Prostatectomy. Mearini L; Nunzi E; Ferri C; Bellezza G; Lolli C; Porrozzi C; Porena M Urol Int; 2015; 95(4):390-9. PubMed ID: 25792149 [TBL] [Abstract][Full Text] [Related]
10. Clinical performance of serum prostate-specific antigen isoform [-2]proPSA (p2PSA) and its derivatives, %p2PSA and the prostate health index (PHI), in men with a family history of prostate cancer: results from a multicentre European study, the PROMEtheuS project. Lazzeri M; Haese A; Abrate A; de la Taille A; Redorta JP; McNicholas T; Lughezzani G; Lista G; Larcher A; Bini V; Cestari A; Buffi N; Graefen M; Bosset O; Le Corvoisier P; Breda A; de la Torre P; Fowler L; Roux J; Guazzoni G BJU Int; 2013 Aug; 112(3):313-21. PubMed ID: 23826841 [TBL] [Abstract][Full Text] [Related]
11. ProPSA and the Prostate Health Index as predictive markers for aggressiveness in low-risk prostate cancer-results from an international multicenter study. Heidegger I; Klocker H; Pichler R; Pircher A; Prokop W; Steiner E; Ladurner C; Comploj E; Lunacek A; Djordjevic D; Pycha A; Plas E; Horninger W; Bektic J Prostate Cancer Prostatic Dis; 2017 Sep; 20(3):271-275. PubMed ID: 28322234 [TBL] [Abstract][Full Text] [Related]
12. Usefulness of the prostate health index in predicting the presence and aggressiveness of prostate cancer among Korean men: a prospective observational study. Kim JY; Yu JH; Sung LH; Cho DY; Kim HJ; Yoo SJ BMC Urol; 2021 Sep; 21(1):131. PubMed ID: 34530786 [TBL] [Abstract][Full Text] [Related]
13. The ability of prostate-specific antigen (PSA) density to predict an upgrade in Gleason score between initial prostate biopsy and prostatectomy diminishes with increasing tumour grade due to reduced PSA secretion per unit tumour volume. Corcoran NM; Casey RG; Hong MK; Pedersen J; Connolly S; Peters J; Harewood L; Gleave ME; Costello AJ; Hovens CM; Goldenberg SL BJU Int; 2012 Jul; 110(1):36-42. PubMed ID: 22085203 [TBL] [Abstract][Full Text] [Related]
14. Preoperative %p2PSA and Prostate Health Index Predict Pathological Outcomes in Patients with Prostate Cancer Undergoing Radical Prostatectomy. Cheng YT; Huang CY; Chen CH; Chiu ST; Hong JH; Pu YS; Liu SP; Lu YC; Chang YK; Chang HC; Huang KH; Lee YJ; Chow PM; Chiang IN; Hung SC; Chiang CH Sci Rep; 2020 Jan; 10(1):776. PubMed ID: 31964956 [TBL] [Abstract][Full Text] [Related]
15. Clinical and pathologic predictors of Gleason sum upgrading in patients after radical prostatectomy: results from a single institution series. Tilki D; Schlenker B; John M; Buchner A; Stanislaus P; Gratzke C; Karl A; Tan GY; Ergün S; Tewari AK; Stief CG; Seitz M; Reich O Urol Oncol; 2011; 29(5):508-14. PubMed ID: 19837614 [TBL] [Abstract][Full Text] [Related]
16. Prostate Health Index ( Yan JQ; Huang D; Huang JY; Ruan XH; Lin XL; Fang ZJ; Gao Y; Jiang HW; Wu YS; Na R; Xu DF Asian J Androl; 2022; 24(4):406-410. PubMed ID: 34782549 [TBL] [Abstract][Full Text] [Related]
17. [Clinical value of serum isoform [-2] proprostate-specific antigen and its derivatives in predicting aggressive prostate cancer]. Sun KX; Yan CL; Li ZY; Liu P; Zhang W; He Q Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Apr; 52(2):234-239. PubMed ID: 32306004 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of prostate-specific antigen isoform p2PSA and its derivates, %p2PSA, prostate health index and prostate dimension-adjusted related index in the detection of prostate cancer at first biopsy: an exploratory, prospective study. Mearini L; Ferri C; Lazzeri M; Bini V; Nunzi E; Fiorini D; Costantini E; Manasse GC; Porena M Urol Int; 2014; 93(2):135-45. PubMed ID: 24732975 [TBL] [Abstract][Full Text] [Related]
19. Role of prostate health index to predict Gleason score upgrading and high-risk prostate cancer in radical prostatectomy specimens. Kim H; Jung G; Kim JH; Byun SS; Hong SK Sci Rep; 2021 Aug; 11(1):17447. PubMed ID: 34465825 [TBL] [Abstract][Full Text] [Related]
20. Prognostic accuracy of Prostate Health Index and urinary Prostate Cancer Antigen 3 in predicting pathologic features after radical prostatectomy. Cantiello F; Russo GI; Ferro M; Cicione A; Cimino S; Favilla V; Perdonà S; Bottero D; Terracciano D; De Cobelli O; Morgia G; Damiano R Urol Oncol; 2015 Apr; 33(4):163.e15-23. PubMed ID: 25575715 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]